Home Medicine Initial validation of the exercise chronic pain acceptance questionnaire
Article Publicly Available

Initial validation of the exercise chronic pain acceptance questionnaire

  • James D. Sessford EMAIL logo and Lawrence R. Brawley
Published/Copyright: October 1, 2017
Become an author with De Gruyter Brill

Abstract

Background and aims

Pain acceptance, measured by the chronic pain acceptance questionnaire (CPAQ), is related to exercise adherence for those with arthritis. The CPAQ measure has 20 items comprising two subscales - pain willingness and activities engagement about pursuing “valued daily activities” despite pain. However, exercise is not specified as a valued activity and respondents may be considering other activities raising generalizability and strength of prediction concerns.

Methods

Accordingly, a modified CPAQ solely for exercise (CPAQ-E) was developed to heighten salience to pursuit of exercise in the face of pain. An exercising sample with arthritis (N=98) completed the CPAQ-E at baseline and exercise 2 weeks later. Exploratory factor analysis of the CPAQ-E was performed using Mplus. Regression was used to predict exercise.

Results

Analysis revealed a two-factor, 14 item model with good psychometric properties reflecting pain willingness and activities engagement subscales (χ2 = 85.695, df=64, p<.037; RMSEA = .055; CFI = .967; TLI = .954). Both subscales and the total score positively predicted future weekly exercise bouts (range ps from < .05 to <.001). Activities engagement predicted future weekly exercise volume (p < .05).

Conclusions

This study offers preliminary support for the factorial and predictive validity of the CPAQ-E among exercising individuals with arthritis.

Implications

This measure could help researchers increase the specificity and sensitivity of pain acceptance responses to exercising among individuals with arthritis. A more sensitive measure might help clinicians interpret patient responses to exercise for pain self-management.

1 Introduction

Physical activity has been recommended as self-management for people with all types of arthritis (e.g., osteoarthritis, rheumatoid arthritis.) by both arthritis and public health advocates. They agree that those with arthritis of all types pursue the same goal of 150 min of moderate to vigorous physical activity (MVPA) to obtain multiple health benefits [1, 2, 3]. However, few people with arthritis meet this guideline [2]. Studies have identified pain acceptance as one potentially helpful psychological correlate in understanding adherence to MVPA [4,5].

What is pain acceptance? Pain acceptance describes a psychological factor that means some individuals acknowledge their pain, discard unproductive means of controlling pain, reject the notion of pain as equivalent to disability, and pursue their valued activities despite pain [6]. The chronic pain acceptance questionnaire (CPAQ) is a measure of pain acceptance [7] that has been developed and validated in chronic pain populations. However, the CPAQ is phrased generally and does not draw respondents’ attention to specific valued activities (e.g., exercise) in answering the CPAQ items.

To explore which activities people had in mind when answering the CPAQ secondary analysis [8] of a larger arthritis exercise barriers investigation was conducted. Following completion of the CPAQ, exercising individuals with arthritis were offered examples of activities (e.g., employment, social, hobbies, household care, exercise, etc.) and they indicated whether each was considered when answering the CPAQ. On average, respondents considered 4 activities which they rated on a 0 (Do not value at all) to 10 (Value very highly) scale, with most of these personally selected activities being highly endorsed. Based on this analysis, these respondents to the original CPAQ concurrently considered many activities and were not exclusively focussed on exercise despite the fact that they were somewhat active and endorsed exercise as valued. Thus, when using the global CPAQ scores to correlate with exercise- specific variables, the correlation may not be a true reflection of the pain acceptance expressed if individuals were focussed on exercise alone.

The author of the original CPAQ was contacted [9] regarding a potential exercise modification and agreed it should be pursued, and did not foresee any reduction in validity if modifications were made. There is also precedent for successful CPAQ modification for other purposes and populations such as a short form [10] and a modification for adolescents [11].

1.1 Objectives and hypotheses

The present study had two related measurement objectives concerning factorial and predictive validity relative to the exercise-oriented version of the CPAQ, hereafter called the CPAQ-E. The first concerned examining the factorial validity of the CPAQ-E.

The second objective concerned the CPAQ-E’s predictive utility and assessed whether the CPAQ-E or its subscales would predict future MVPA.

2 Methods

2.1 Participants and design

The study design was prospective, observational. Ninety-eight adults with self-reported, medically-diagnosed arthritis completed surveys at baseline and two weeks later. To participate, the following eligibility criteria were met: (a) 18 years of age or older, (b) residents of Canada or the United States, (c) report doing at least one bout of planned physical activity in the past 4 weeks lasting 15 min or more, (d) report having medically-diagnosed arthritis.

2.2 Measures

Pain acceptance for exercise. Pain acceptance was assessed using an exercise-oriented modification of the CPAQ [7] called the CPAQ-E. The original 20-item CPAQ is comprised of 2 subscales (pain willingness and activities engagement) and can also be interpreted as a total score. The CPAQ-E specified the wording of each original item to focus respondents’ attention on exercise behaviour. A sample item from the pain willingness subscale is “I need to concentrate on getting rid of my pain before I can exercise” (originally “I need to concentrate on getting rid of my pain”). A sample from the activities engagement subscale is “I am getting on with my exercise plans no matter what my level of pain is” (originally “I am getting on with the business of living no matter what my level of pain is”). Participants rated each item in terms of how true it was for themselves on a 0 (never true) to 6 (always true) response scale. As with the original measure, CPAQ-E items in the pain willingness scale were reverse scored and summed while the activities engagement items were summed. The total CPAQ-E score was calculated by summing the 2 subscales. Higher scores on both subscales and for the total score represent higher pain acceptance, up to a maximum score of 114. The CPAQ has been validated in chronic pain populations [7] with good internal consistency and the CPAQ-E was internally consistent in the present study (Cronbach’s α = .92).

Physical activity. Participants reported the average weekly frequency and duration over the past two weeks of planned bouts of moderate and vigorous activity lasting at least 15 min. Total weekly planned PA volume was calculated in a manner consistent with public health recommendations and previous work on PA and arthritis [2,12,13]. Definitions of moderate and vigorous activity were provided to participants. Moderate activity was defined as “...makes your heart beat faster and makes you breathe a little harder. You can talk easily while doing moderate activity, but you may not be able to sing comfortably. On a scale from 0 to 10, where sitting is 0 and the highest level of effort possible is 10, moderate exercise is a 5 or 6. Vigorous activity was defined as “. . . makes your heart beat much faster. You may not be able to talk comfortably without stopping to catch your breath. On a scale of 0 to 10, where sitting is 0 and the highest level of effort possible is 10, vigorous activity is a 7 or 8.”

Activity bouts of less than 15 min were not assessed because the present study focused on planned activity that required self regulation. This is in contrast to unplanned, shorter incidental bouts. Planned bouts of longer duration have also demonstrated better recall and are self-reported with higher accuracy than unplanned, incidental short duration bouts of activity [14]. In the present study, pain-related beliefs about planned MVPA was used to predict the correspondent planned MVPA bout frequency and minutes (i.e., volume). What is being self-regulated is the time individuals take to complete a given bout of either moderate and/or vigorous activity in excess of 15 continuous minutes. Therefore, the total volume of planned PA per week was calculated with a focus on minutes of either kind of activity as defined in the measure’s instructions. Accordingly, weekly moderate activity (frequency × duration) and weekly vigorous activity (frequency × duration) were summed for total volume. Frequency represented the number of planned weekly bouts of MVPA and this was used as an additional behavioural indicant of exercise.

2.3 Procedures

Upon obtaining approval from the University Behavioural Research Ethics Board, web-based study announcements were used to recruit the study sample. These announcements included a link to the online survey and were posted to arthritis newsletters and to national arthritis organisations’ official websites (e.g., the Arthritis Society, local chronic disease programme, etc.). Announcements were also posted to social media pages of these organizations (e.g., Facebook, Twitter).

At the onset of the online survey, participants were required to complete the electronic consent form. After answering questions pertaining to eligibility criteria, participants completed the 20-30 min survey, which included the CPAQ-E. A link to the brief follow-up survey consisting of the exercise measure was sent by email two weeks later to those participants who provided their permission.

2.4 Data management and analytical plan

Analyses were performed using SPSS version 23 and Mplus. Data were screened for outliers and for missing data. Mean item score replacement for a given individual was used for an individual’s scales that were missing a single item [15]. A small number of participants reported either the days or minutes of exercise (n = 2) and one was missing both. A conservative strategy was utilized for replacing the missing MVPA data whereby the lowest possible answer was inserted (i.e., 1 day, or 15 min - if minutes were reported, they must have been performed on at least 1 day). For inclusion, activity bouts needed to be 15 min or more.

Z-scores greater than 3.29 indicated outliers and were only found in the weekly MVPA volume scores. These outliers were handled according to recommendations by Tabachnick and Fidell [15] such that the lowest score among the outliers was reduced to 1 score (1 min) greater than the next largest MVPA score. This procedure addresses the problem of an outlier while maintaining rank order of individual values.

To examine the objective regarding factorial validity, an exploratory factor analysis (EFA) was conducted on the CPAQ-E measure using Mplus 7.31 [16], using Mplus’s robust maximum likelihood estimator (MLR) with a geomin rotation. MLR estimation is robust to violations of normality [16]. Mplus factor analysis was performed using an iterative procedure. Advantages of using Mplus rather than SPSS for factor analysis include use of a gold standard method (maximum likelihood) for estimating missing data and provision of significance tests for factor loadings [16]. Assumptions of the analysis were tested and met including sampling adequacy and controlling outliers. The original CPAQ consists of 2 correlated subscales. Thus, an oblique rotation was used.

A second study objective concerned predictive validity of the CPAQ-E. Predictions were examined using simple linear regressions. Assumptions of regression were tested and met including multicollinearity and homoscedasicity. Separate regressions were conducted using each of the potential predictors (CPAQ-E total score and each of the 2 subscales) as the independent variable and MVPA as the dependent variable (both MVPA volume and MVPA bouts were analyzed as the dependent variable in separate analyses).

3 Results

One-hundred ninety participants began the Time 1 survey. Participant exclusion and attrition was as follows: 29 participants were excluded for eligibility reasons, 25 failed to complete the second survey, and 38 began survey 1 but did not complete it. The majority of the final sample (N = 98, Mage = 49.66 ±14.23 years) was white (91.8%), female (86%), and completed some form of post-secondary education (89.8%). Just over half (51%) were married. The number of years since arthritis diagnosis varied from less than a year (7.1%), 1-5 years (22.4%), 6-10 years (21.4%), 11-15 years (20.4%), 16-20 years (6.1%), to over 20 years (22.4%). The sample reported using medication to control their arthritis (84.7%). The most commonly reported co-morbidities included depression (20.4%), high blood pressure (17.3%), thyroid (16.3%), while 27.6% reported no co-morbidities.

3.1 Pain acceptance factor structure

Item 9 from the 20-item original CPAQ measure was excluded due to an error during building the online survey. When analyzed using Mplus, the initial 19-item CPAQ-E model had poor fit when the expected 2-factor solution that constitutes the original CPAQ was examined (e.g., significant χ2, RMSEA>0.10). Consequently, an iterative procedure was then undertaken whereby items were omitted one at a time to assess the effect of their removal on the model. This approach resulted in the removal of items 2, 4, 5, 10, and 16. The reasons for item removal were as follows. Item 2 was multi-collinear with item 6 as indicated by modification indices (θ = 36.88) and a correlation of .72. Items 4, 5, 10, and 16 did not load significantly on either factor.

The reduced 14-item scale resulted in a 2-factor model with good fit indices as can be seen in Table 1 (RMSEA= .055, CFI = .97). As illustrated by Table 2, all CPAQ-E items in the reduced model loaded on the expected subscale consistent with the original CPAQ conceptualization. Regarding psychometrics, both subscales were internally consistent (Cronbach’s α = .88). Descriptive statistics and correlations between CPAQ-E subscales can be found in Table 3.

Table 1

CPAQ-E factor models.

# of items # of factors Fit indices

Chi-square analyses RMSEA analysis CFI TLI




χ2 df p RMSEA 90% Cl CFI TLI
19 1 400.648 152 <.001 .121 .107-.136 .733 .700
2 296.886 134 <.001 .105 .089-.121 .825 .777
14 1 182.474 77 <.001 .111 .090-.132 .841 .812
2 85.69 64 .037 .055 .015-.084 .967 .954
  1. Note: RMSEA: root mean square error of approximation; CFI: comparative fit index; TLI: Tucker-Lewis index. Models examined reflect the 19- and 14-item versions of the CPAQ-E. Boldface coefficients display the fit indices of the 14-item, two-factor retained model

Table 2

Factor loadings for the final 14-item model of CPAQ-E.

Item description Factor one Factor two
1. I am getting on with my exercise plans no matter what my level of pain is.[a] .90 -.06
3. It’s OK to experience pain during exercise.[a] .34 .17
6. Although things have changed, I am able to exercise despite my chronic pain.[a] .43 .26
7. I need to concentrate on getting rid of my pain before I can exercise.[b] .08 .67
8. There are many activities I do when I feel pain, such as exercise.[a] .76 -.01
11. My thoughts and feelings about pain must change before I can exercise.[b] -.02 .72
12. Despite the pain, I am now sticking to my exercise plans.[a] .84 .04
13. Keeping my pain level under control takes first priority, above exercising.[b] .21 .69
14. Before I can make any serious exercise plans, I have to get some control over my pain.[b] .19 .72
15. When my pain increases, I can still exercise.[a] .68 .19
17. I avoid putting myself in exercise situations where my pain might increase.[b] -.23 .87
18. My worries and fears about what exercise-related pain will do to me are true.[b] .03 .78
19. It’s a relief to realize that I don’t have to change my pain to get on with my exercise plans.[a] .55 .14
20. I have to struggle to do exercise when I have pain.[b] -.04 .55
  1. Note: Boldfaced coefficients represent loadings retained for each factor. Excluded items were as follows: Item 2. My exercise is going well, even though I have chronic pain.; Item 4. I would gladly sacrifice exercise to control this pain better.; Item 5. It’s not necessary for me to control my pain in order to exercise.; Item 10. Controlling pain is less important than exercise.; Item 16. I will have better control over my exercise plans if I can control my negative thoughts about pain

Table 3

Correlations and descriptives for CPAQ-E.

Measure M ± SD 1. 2. 3.
1. Activities engagement 36.9 ±10.2 - .683[**] .918[**]
2. Pain willingness 29.7 ±10.1 - - .916[**]
3. CPAQ-E total 66.5± 18.6 - - -

3.2 Predicting physical activity volume

Weekly volume. Using the various independent variables as single predictors, the results were as follows. The CPAQ-E activities engagement subscale significantly predicted weekly minutes of planned MVPA (R2Adj. = .05, p = .014) but in separate analyses, each of the total score and the pain willingness subscale did not.

Weekly bouts. Each of the independent variables was used to predict bouts of planned activity. The CPAQ-E activities engagement subscale significantly predicted weekly bouts of MVPA (R2Adj. = .126, p< .001) as did the total score (R2Adj. = .084, p = .002) and the pain willingness subscale (R2Adj. = .033, p < .05).

4 Discussion

The CPAQ represents people’s willingness to pursue valued daily activities despite pain. The CPAQ has demonstrated utility in exercise studies such that higher scores correspond with higher levels of PA volume [4,5]. However, an obvious critique of the use of the original measure for exercise studies is that people may be thinking of a variety of “valued activities” (e.g., employment, family care, etc.) and not just exercise when answering the CPAQ items [8]. This response would represent more global pain acceptance rather than a response salient to engaging in exercise regardless of pain. An exercise-specific modification to the CPAQ may be more appropriate for use in exercise studies [9]. The present study sought to assess the exercise-specific CPAQ-E in terms of factorial validity, reliability, and predictive validity. Findings support initial evidence of the factorial and predictive validity of the CPAQ-E. Specifically, the final 14 item two-factor CPAQ-E is conceptually consistent with the original 20 item measure’s (CPAQ) operationalization as a two-factor construct. CPAQ-E items loaded on the same subscales as on the original CPAQ (activities engagement and pain willingness) and have acceptable reliability scores.

Regarding predictive validity, the activities engagement subscale is the only score on the CPAQ-E that predicted weekly minutes of activity. However, the total score and both CPAQ-E subscales significantly predicted weekly bouts of activity. One possible explanation for these results is that recall for number of bouts is better than for total weekly minutes suggesting that the measurement error associated with recall of minutes may be partly the reason for differences in predictive utility. Depending on the pain acceptance research question of interest in future studies, it is important to be aware of the correspondence between CPAQ-E predictor variables and the nature of the dependent measures of interest. Arbitrary selection of predictors and outcomes and how they are measured (e.g., non-correspondence between a specific CPAQ-E subscale and a general outcome such as calories burned in exercise) could inflate measurement error or constrain variability in both measures thereby leading to reduced predictive utility.

4.1 Strengths and limitations

This study provides initial evidence that may improve decision making regarding choice of pain acceptance measures in studies of exercise and arthritis. It is the first test of an exercise-specific modification of the CPAQ. The strength of this study is that it is a first step towards testing a pain acceptance measure which focuses respondents on exercise behaviour and away from various other valued activities. General measures used without taking context and salience into account might not have the validity necessary to answer questions about pain acceptance and exercise among individuals with arthritis. For example, correspondence between predictive measures and the behaviour of interest has been highlighted as important in self-efficacy measurement among individuals with chronic disease [17,18]. Salience to respondents with pain is also considered to be important for other predictors of exercise behaviour such as self-efficacy [18] and in psychological problem solving research, the importance of correspondence between salient methodology (i.e., measurement) and specific samples is highlighted, thus focussing respondents on the target behaviour [19]. Using that idea in the present study, the same care and intent was taken by modifying the CPAQto enhance correspondence between the CPAQ-E and frequency of exercise.

Given this investigation is an initial study of the CPAQ-E, it is important to be mindful of its limitations. The first is related to generalizability given the predominantly female sample and the fact that recruitment efforts yielded a select sample who access arthritis groups. This limits the generalizability about males with arthritis and those not accessing arthritis groups via their websites and social media. However, females tend to be the predominant part of the samples in other studies of exercise and arthritis [20]. Thus, the proportion of the genders who volunteered for the present study is similar to that reported in other published exercise and arthritis research.

A second limitation may be the use of a self-report exercise measure as opposed to objective measures (e.g., accelerometry). However, there are also limitations of the use of accelerometry in chronic pain populations, including those with chronic disease or physical impairment. For example, a recent study by Rejeski and colleagues [21] of older adults in the LIFE intervention found extreme variability in median accelerometry counts per minute achieved during a controlled bout of exercise. Further, they noted that objectively defining MVPA intensity for exercise prescription using set cut points for older adults with different disabilities may be inconsistent with their performance capability and may be inadvisable to use for setting goals, examining adherence, or considering change. The reality of using perceptual cues to guide exercise counselling is advised.

This advice pairs well with importance ofparticipants’ estimates of the willingness to accept pain in order to exercise. For example, for adults with peripheral artery disease who experience pain in their lower extremities, objectively assessed moderate activity prescription will not only be influenced by pain symptoms in their lower extremities but also by their perceived willingness to accept this pain in order to pursue their prescription [22]. Thus, an objectively assessed generic activity prescription may not match well with perceptions guiding actual capability.

A third and final limitation is that the original CPAQ measure was not included in this study. This was a conscious decision to reduce subject burden, realizing it constrained the ability to directly compare responses between the CPAQ and CPAQ-E for the same subject. Whereas the CPAQ-E is similar to the original, it also differs with respect to (a) its references t exercise in each item to increase salience and focus participants exclusively on exercise and (b) having five fewer items.

The CPAQ-E had over one quarter of its items removed through the exploratory factor analytic process. This finding speaks to the possibility that in other exercise studies, including our own, use of the original CPAQ and its more global pain acceptance response for a variety of activities (i.e., vs exercise alone), may have reduced the sensitivity of the measure with respect to an exclusively exercise response. Given the differences between the two pain acceptance measures, direct comparisons may not be possible but comparison through identification of the strength of pain acceptance or the predictive utility of the measures seems more likely.

There is precedent in the literature for other CPAQmodifications not being compared to the original measure. For example, initial study of another CPAQ modification, the CPAQ-A for adolescents [11], was made without a direct comparison to the original CPAQ.

Regardless, a future comparison of the utility of the CPAQ and the CPAQ-E in predicting PA would be of value. It may be prudent to compare each measure using separate randomly-selected subgroups within the same large sample (i.e., exercisers with chronic pain) to determine if there are differences in CPAQ and CPAQ-E responses between subgroups of the larger homogeneous sample.

As well, future studies should examine test-retest reliability relative to the stability of the CPAQ-E scores across multiple measurement time points. Finally, and relative to factorial validity, gathering data from additional samples should be a future research goal in order to examine its factor structure via confirmatory factor analysis [23].

5 Conclusions

The present study offers preliminary support for the utility of the CPAQ-E in studies of exercise and arthritis. Further examination of the CPAQ-E’s utility in predicting exercise behaviour or differentiating among exercising individuals and the inactive in the broader chronic pain population is also suggested.

Highlights

  • An exercise-specific chronic pain acceptance questionnaire (CPAQ-E) is tested.

  • The CPAQ-E demonstrated acceptable face validity, factor structure and reliability.

  • The CPAQ-E predicted future bouts of planned exercise behaviour in this sample.

  1. Funding: Canada Research Chairs Programme Training Funds.

  2. Ethical issues: Ethics board approval was obtained, informed consent was obtained, and study protocol was not registered.

  3. Conflicts of interest: None declared.

References

[1] Arthritis Society. The Arthritis Society’s five-year strategic research plan, 2011-16. https://arthritis.ca/page.aspx?pid=1172 [accessed 17.09.15].Search in Google Scholar

[2] Public Health Agency of Canada Centre for Chronic Disease Prevention and Control, & Chronic Disease Surveillance Division. Life with arthritis in Canada: a personal and public health challenge; 2015. http://www.phac-aspc.gc.ca/cd-mc/arthritis-arthrite/lwaic-vaaac-10/pdf/arthritis-2010-eng.pdf[accessed 17.09.15].Search in Google Scholar

[3] Alliance for the Canadian Arthritis Program.Report from the summit on standards for arthritis prevention and care. http://www.arthritisalliance.ca/images/PressReleases/ACAP_20Release_20English_20FINAL.pdf [accessed 17.09.15].Search in Google Scholar

[4] Gyurcsik NC, Brawley LR, Spink KS, Glazebrook KE, Anderson TJ. Is level of pain acceptance differentially related to social cognitions and behavior? The case of active women with arthritis. J Health Psychol 2011;16:530–9, http://dx.doi.org/10.1177/1359105310394229.Search in Google Scholar

[5] Flora PK, Brawley LR, Sessford JD, Cary MA, Gyurcsik NC. Predicting planned physical activity of individuals with arthritis: a self-regulatory perspective. J Health Psychol 2015, 1359105315583370[pii].Search in Google Scholar

[6] McCracken LM. Learning to live with the pain: acceptance of pain predicts adjustment in persons with chronic pain. Pain 1998;74:21–7. S0304-3959(97)00146-2.Search in Google Scholar

[7] McCracken LM, Vowles KE, Eccleston C. Acceptance of chronic pain: component analysis and a revised assessment method. Pain 2004;107:159–66, pii:S0304395903004299.Search in Google Scholar

[8] Sessford JD (Ph.D.) Do coping strategies for pain mediate between psychosocial factors and physical activity for people with chronic pain? University of Saskatchewan; 2017.Search in Google Scholar

[9] McCracken LM. Personal communication. 2014.Search in Google Scholar

[10] Rovner GS, Arestedt K, Gerdle B, Borsbo B, McCracken LM. Psychometric properties of the 8-item Chronic Pain Acceptance Questionnaire (CPAQ-8) in a Swedish chronic pain cohort. J Rehabil Med 2014;46:73–80, http://dx.doi.org/10.2340/16501977-1227.Search in Google Scholar

[11] McCracken LM, Gauntlett-Gilbert J, Eccleston C. Acceptance of pain in adolescents with chronic pain: validation of an adapted assessment instrument and preliminary correlation analyses. Eur J Pain 2010;14:316–20, http://dx.doi.org/10.1016Zj.ejpain.2009.05.002.Search in Google Scholar

[12] Centers for Disease Control and Prevention. Physical activity and arthritis overview. http://www.cdc.gov/arthritis/pa_overview.htm#3 [accessed 17.09.15].Search in Google Scholar

[13] Gyurcsik NC, Brawley LR, Spink KS, Sessford JD. Meeting physical activity recommendations: self-regulatory efficacy characterizes differential adherence during arthritis flares. Rehabil Psychol 2013;58:43–50, http://dx.doi.org/10.1037/a0031293.Search in Google Scholar

[14] Cust AE, Smith BJ, Chau J, van der Ploeg HP, Friedenreich CM, Armstrong BK, Bauman A. Validity and repeatability of the EPIC physical activity questionnaire: a validation study using accelerometers as an objective measure. Int J Behav Nutr Phys Act 2008;5, http://dx.doi.org/10.1186/1479-5868-5-33.Search in Google Scholar

[15] Tabachnick BG, Fidell LS. Using multivariate statistics. Boston, MA: Pearson/Allyn & Bacon; 2012.Search in Google Scholar

[16] Muthen LK, Muthen BO. Mplus user’s guide. 7th ed. Los Angeles, CA: Muthén & Muthén; 1998-2012.Search in Google Scholar

[17] Frei A, Svarin A, Steurer-Stey C, Puhan MA. Self-efficacy instruments for patients with chronic diseases suffer from methodological limitations - a systematic review. Health Qual Life Outcomes 2009;7, http://dx.doi.org/10.1186/1477-7525-7-86.Search in Google Scholar

[18] Marks R. Self-efficacy and its application in the treatment of knee osteoarthritis: a critical review. Rheumatol Rep 2012;4:34–45, http://dx.doi.org/10.4081/rr.2012.e10.Search in Google Scholar

[19] Elliott TR, Grant JS, Miller DM. Social problem-solving abilities and behavioral health. In: Chang EC, D’Zurilla TJ, Sanna L, editors. Social problem solving: theory, research, and training. Washington, DC: American Psychological Association; 2004. p. 117-33.Search in Google Scholar

[20] Gyurcsik NC, Cary MA, Sessford JD, Flora PK, Brawley LR. Pain, anxiety, and negative outcome expectations for activity: do negative psychological profiles differ between the inactive and active? Arthritis Care Res (Hoboken) 2015;67:58–64, http://dx.doi.org/10.1002/acr.22421.Search in Google Scholar

[21] Rejeski WJ, Marsh AP, Brubaker PH, Buman M, Fielding RA, Hire D, Manini T, Rego A, Miller ME, Study LIFE, Investigators.Analysis and interpretation of accelerometry data in older adults: the LIFE study. J Gerontol A Biol Sci Med Sci 2016;71:521–8, http://dx.doi.org/10.1093/gerona/glv204.Search in Google Scholar

[22] Rejeski WJ, Tian L, Liao Y, McDermott MM. Social cognitive constructs and the promotion of physical activity in patients with peripheral artery disease. J Cardiopulm Rehabil Prev 2008;28:65–72, http://dx.doi.org/10.1097/01.HCR.0000311512.61967.6e.Search in Google Scholar

[23] Cudeck, R, MacCallum, RC, eds. Factor analysis at 100: historical developments and future directions. Routledge; 2007.Search in Google Scholar

Received: 2017-07-06
Revised: 2017-09-19
Accepted: 2017-09-20
Published Online: 2017-10-01
Published in Print: 2017-10-01

© 2017 Scandinavian Association for the Study of Pain

Articles in the same Issue

  1. Observational study
  2. Perceived sleep deficit is a strong predictor of RLS in multisite pain – A population based study in middle aged females
  3. Clinical pain research
  4. Prospective, double blind, randomized, controlled trial comparing vapocoolant spray versus placebo spray in adults undergoing intravenous cannulation
  5. Clinical pain research
  6. The Functional Barometer — An analysis of a self-assessment questionnaire with ICF-coding regarding functional/activity limitations and quality of life due to pain — Differences in age gender and origin of pain
  7. Clinical pain research
  8. Clinical outcome following anterior arthrodesis in patients with presumed sacroiliac joint pain
  9. Observational study
  10. Chronic disruptive pain in emerging adults with and without chronic health conditions and the moderating role of psychiatric disorders: Evidence from a population-based cross-sectional survey in Canada
  11. Educational case report
  12. Management of patients with pain and severe side effects while on intrathecal morphine therapy: A case study
  13. Clinical pain research
  14. Behavioral inhibition, maladaptive pain cognitions, and function in patients with chronic pain
  15. Observational study
  16. Comparison of patients diagnosed with “complex pain” and “somatoform pain”
  17. Original experimental
  18. Patient perspectives on wait times and the impact on their life: A waiting room survey in a chronic pain clinic
  19. Topical review
  20. New evidence for a pain personality? A critical review of the last 120 years of pain and personality
  21. Clinical pain research
  22. A multi-facet pain survey of psychosocial complaints among patients with long-standing non-malignant pain
  23. Clinical pain research
  24. Pain patients’ experiences of validation and invalidation from physicians before and after multimodal pain rehabilitation: Associations with pain, negative affectivity, and treatment outcome
  25. Observational study
  26. Long-term treatment in chronic noncancer pain: Results of an observational study comparing opioid and nonopioid therapy
  27. Clinical pain research
  28. COMBAT study – Computer based assessment and treatment – A clinical trial evaluating impact of a computerized clinical decision support tool on pain in cancer patients
  29. Original experimental
  30. Quantitative sensory tests fairly reflect immediate effects of oxycodone in chronic low-back pain
  31. Editorial comment
  32. Spatial summation of pain and its meaning to patients
  33. Original experimental
  34. Effects of validating communication on recall during a pain-task in healthy participants
  35. Original experimental
  36. Comparison of spatial summation properties at different body sites
  37. Editorial comment
  38. Behavioural inhibition in the context of pain: Measurement and conceptual issues
  39. Clinical pain research
  40. A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis
  41. Editorial comment
  42. Quantitative sensory tests (QST) are promising tests for clinical relevance of anti–nociceptive effects of new analgesic treatments
  43. Educational case report
  44. Pregabalin as adjunct in a multimodal pain therapy after traumatic foot amputation — A case report of a 4-year-old girl
  45. Editorial comment
  46. Severe side effects from intrathecal morphine for chronic pain after repeated failed spinal operations
  47. Editorial comment
  48. Opioids in chronic pain – Primum non nocere
  49. Editorial comment
  50. Finally a promising analgesic signal in a long-awaited new class of drugs: TRPV1 antagonist mavatrep in patients with osteoarthritis (OA)
  51. Observational study
  52. The relationship between chronic musculoskeletal pain, anxiety and mindfulness: Adjustments to the Fear-Avoidance Model of Chronic Pain
  53. Clinical pain research
  54. Opioid tapering in patients with prescription opioid use disorder: A retrospective study
  55. Editorial comment
  56. Sleep, widespread pain and restless legs — What is the connection?
  57. Editorial comment
  58. Broadening the fear-avoidance model of chronic pain?
  59. Observational study
  60. Identifying characteristics of the most severely impaired chronic pain patients treated at a specialized inpatient pain clinic
  61. Editorial comment
  62. The burden of central anticholinergic drugs increases pain and cognitive dysfunction. More knowledge about drug-interactions needed
  63. Editorial comment
  64. A case-history illustrates importance of knowledge of drug-interactions when pain-patients are prescribed non-pain drugs for co-morbidities
  65. Editorial comment
  66. Why can multimodal, multidisciplinary pain clinics not help all chronic pain patients?
  67. Topical review
  68. Individual variability in clinical effect and tolerability of opioid analgesics – Importance of drug interactions and pharmacogenetics
  69. Editorial comment
  70. A new treatable chronic pain diagnosis? Flank pain caused by entrapment of posterior cutaneous branch of intercostal nerves, lateral ACNES coined LACNES
  71. Clinical pain research
  72. PhKv a toxin isolated from the spider venom induces antinociception by inhibition of cholinesterase activating cholinergic system
  73. Clinical pain research
  74. Lateral Cutaneous Nerve Entrapment Syndrome (LACNES): A previously unrecognized cause of intractable flank pain
  75. Editorial comment
  76. Towards a structured examination of contextual flexibility in persistent pain
  77. Clinical pain research
  78. Context sensitive regulation of pain and emotion: Development and initial validation of a scale for context insensitive avoidance
  79. Editorial comment
  80. Is the search for a “pain personality” of added value to the Fear-Avoidance-Model (FAM) of chronic pain?
  81. Editorial comment
  82. Importance for patients of feeling accepted and understood by physicians before and after multimodal pain rehabilitation
  83. Editorial comment
  84. A glimpse into a neglected population – Emerging adults
  85. Observational study
  86. Assessment and treatment at a pain clinic: A one-year follow-up of patients with chronic pain
  87. Clinical pain research
  88. Randomized, double-blind, placebo-controlled, dose-escalation study: Investigation of the safety, pharmacokinetics, and antihyperalgesic activity of L-4-chlorokynurenine in healthy volunteers
  89. Clinical pain research
  90. Prevalence and characteristics of chronic pain: Experience of Niger
  91. Observational study
  92. The use of rapid onset fentanyl in children and young people for breakthrough cancer pain
  93. Original experimental
  94. Acid-induced experimental muscle pain and hyperalgesia with single and repeated infusion in human forearm
  95. Original experimental
  96. Swearing as a response to pain: A cross-cultural comparison of British and Japanese participants
  97. Clinical pain research
  98. The cognitive impact of chronic low back pain: Positive effect of multidisciplinary pain therapy
  99. Clinical pain research
  100. Central sensitization associated with low fetal hemoglobin levels in adults with sickle cell anemia
  101. Topical review
  102. Targeting cytokines for treatment of neuropathic pain
  103. Original experimental
  104. What constitutes back pain flare? A cross sectional survey of individuals with low back pain
  105. Original experimental
  106. Coping with pain in intimate situations: Applying the avoidance-endurance model to women with vulvovaginal pain
  107. Clinical pain research
  108. Chronic low back pain and the transdiagnostic process: How do cognitive and emotional dysregulations contribute to the intensity of risk factors and pain?
  109. Original experimental
  110. The impact of the Standard American Diet in rats: Effects on behavior, physiology and recovery from inflammatory injury
  111. Educational case report
  112. Erector spinae plane (ESP) block in the management of post thoracotomy pain syndrome: A case series
  113. Original experimental
  114. Hyperbaric oxygenation alleviates chronic constriction injury (CCI)-induced neuropathic pain and inhibits GABAergic neuron apoptosis in the spinal cord
  115. Observational study
  116. Predictors of chronic neuropathic pain after scoliosis surgery in children
  117. Clinical pain research
  118. Hospitalization due to acute exacerbation of chronic pain: An intervention study in a university hospital
  119. Clinical pain research
  120. A novel miniature, wireless neurostimulator in the management of chronic craniofacial pain: Preliminary results from a prospective pilot study
  121. Clinical pain research
  122. Implicit evaluations and physiological threat responses in people with persistent low back pain and fear of bending
  123. Original experimental
  124. Unpredictable pain timings lead to greater pain when people are highly intolerant of uncertainty
  125. Original experimental
  126. Initial validation of the exercise chronic pain acceptance questionnaire
  127. Clinical pain research
  128. Exploring patient experiences of a pain management centre: A qualitative study
  129. Clinical pain research
  130. Narratives of life with long-term low back pain: A follow up interview study
  131. Observational study
  132. Pain catastrophizing, perceived injustice, and pain intensity impair life satisfaction through differential patterns of physical and psychological disruption
  133. Clinical pain research
  134. Chronic pain disrupts ability to work by interfering with social function: A cross-sectional study
  135. Original experimental
  136. Evaluation of external vibratory stimulation as a treatment for chronic scrotal pain in adult men: A single center open label pilot study
  137. Observational study
  138. Impact of analgesics on executive function and memory in the Alzheimer’s Disease Neuroimaging Initiative Database
  139. Clinical pain research
  140. Visualization of painful inflammation in patients with pain after traumatic ankle sprain using [11C]-D-deprenyl PET/CT
  141. Original experimental
  142. Developing a model for measuring fear of pain in Norwegian samples: The Fear of Pain Questionnaire Norway
  143. Topical review
  144. Psychoneuroimmunological approach to gastrointestinal related pain
  145. Letter to the Editor
  146. Do we need an updated definition of pain?
  147. Narrative review
  148. Is acetaminophen safe in pregnancy?
  149. Book Review
  150. Physical Diagnosis of Pain
  151. Book Review
  152. Advances in Anesthesia
  153. Book Review
  154. Atlas of Pain Management Injection Techniques
  155. Book Review
  156. Sedation: A Guide to Patient Management
  157. Book Review
  158. Basics of Anesthesia
Downloaded on 29.12.2025 from https://www.degruyterbrill.com/document/doi/10.1016/j.sjpain.2017.09.016/html
Scroll to top button